- New Rite Aid group VP pharmacy initiatives and clinical services to oversee Wellness Ambassador program
- Shoppers Drug Mart report: Allowing pharmacists in Canada to immunize could save lives, money
- CDC: Flu vaccination prevented an estimated 6.6 million influenza-associated illnesses last season
- Prevention key as people forgo sick days
- CDC: Flu season past its peak but still going strong
LONDON — Lingering fears of pandemic flu in the United States and a spike in flu activity will help to keep vaccination levels high, according to a new report.
GlobalData, a British market research firm, released a report Monday showing that seasonal influenza vaccine demand will increase from 2012's estimated 142 million to 158 million in 2022.
The report noted that after the H1N1 pandemic caused thousands of deaths in the United States in 2009, the number of those being vaccinated every year increased from 2007's 24% to 41% in 2010 among those ages 5 to 64 years, according to the Centers for Disease Control and Prevention.
The driver for the growth in vaccinations will be the increase in the U.S. population and the rise in those considered high-risk, such as the elderly and people with pre-existing medical conditions.